Wilfred van Zuilen - 01 Jul 2022 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Wilfred van Zuilen (power of attorney previously filed)
Issuer symbol
ZBH
Transactions as of
01 Jul 2022
Net transactions value
-$55,870
Form type
4
Filing time
06 Jul 2022, 16:08:48 UTC
Previous filing
23 Feb 2022
Next filing
08 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +2,633 +1908% $0.000000 2,771 01 Jul 2022 Direct F1
transaction ZBH Common Stock Sale $55,870 -531 -19% $105.22 2,240 05 Jul 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Options Exercise $0 -2,633 -25% $0.000000 7,897 01 Jul 2022 Common Stock 2,633 $0.000000 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan through January 10, 2022.
F2 The shares were sold to cover taxes associated with the settlement of restricted stock units ("RSUs").
F3 Each RSU represents a contingent right to receive one share of the Company's common stock.
F4 Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit.
F5 2,633 of the RSUs vested on July 1, 2022 and the remaining 7,897 RSUs are scheduled to vest in thirds on each of July 1, 2023, 2024 and 2025.